Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Qingyuan Zhan"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundLung cancer is the deadliest and most prevalent malignancy worldwide. While smoking is an established cause, evidence to identify other causal factors remains lacking. Current research indicates chronic inflammation is involved in tumorigen
Externí odkaz:
https://doaj.org/article/a96ba1f94b4c4669b2a2faf08f539c42
Autor:
Lin Jia, Junning Peng, Nan Sun, Hongying Chen, Zhenyu Liu, Wenhui Zhao, Qingyuan Zhang, Liru Li
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background This study was designed to evaluate the effect of progesterone receptor (PR) status on the prognosis of advanced estrogen receptor (ER)-high human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients receiving
Externí odkaz:
https://doaj.org/article/db864a84e2af434083a1909245e3213a
Autor:
Jiayu Wang, Yunjiang Liu, Qingyuan Zhang, Wei Li, Jifeng Feng, Xiaojia Wang, Jianmin Fang, Yiqun Han, Binghe Xu
Publikováno v:
Cancer Communications, Vol 44, Iss 7, Pp 833-851 (2024)
Abstract Background Disitamab vedotin (DV; RC48‐ADC) is an antibody‐drug conjugate comprising a human epidermal growth factor receptor 2 (HER2)‐directed antibody, linker and monomethyl auristatin E. Preclinical studies have shown that DV demons
Externí odkaz:
https://doaj.org/article/757642349b7144cda4aed13ff47ad39a
Autor:
Xiaojian Zhu, Changxue Li, Yunfei Gao, Qingyuan Zhang, Tao Wang, Huaixiang Zhou, Fanqin Bu, Jia Chen, Xinjun Mao, Yulong He, Kaiming Wu, Ningning Li, Hongliang Luo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-21 (2024)
Abstract Background Chemoresistance presents a significant obstacle in the treatment of colorectal cancer (CRC), yet the molecular basis underlying CRC chemoresistance remains poorly understood, impeding the development of new therapeutic interventio
Externí odkaz:
https://doaj.org/article/3b7f6890472442379f21b27ed86ffa1c
Autor:
Jianli Ma, Yuwei Deng, Dawei Chen, Xiaomei Li, Zhiyong Yu, Haibo Wang, Lei Zhong, Yingjie Li, Chengqin Wang, Xiang Li, Jinming Yu, Qingyuan Zhang
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-14 (2023)
Abstract Some triple-negative breast cancer (TNBC) patients evaluated as Miller-Payne 4 with ypN0 after neoadjuvant chemotherapy (NACT) who have better prognoses should avoid escalation of therapy. We aim to identify these patients by evaluating pret
Externí odkaz:
https://doaj.org/article/85b973eb4ee94a558a7b69d5efc2f5bb
Autor:
Jianhua Chen, Zhijun Li, Zhonghua Han, Deyong Kang, Jianli Ma, Yu Yi, Fangmeng Fu, Wenhui Guo, Liqin Zheng, Gangqin Xi, Jiajia He, Lida Qiu, Lianhuang Li, Qingyuan Zhang, Chuan Wang, Jianxin Chen
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background Tumor necrosis (TN) was associated with poor prognosis. However, the traditional classification of TN ignored spatial intratumor heterogeneity, which may be associated with important prognosis. The purpose of this study was to pro
Externí odkaz:
https://doaj.org/article/ebf15282658341ff8a273b4a5a718094
Autor:
Lijie Zhang, Chuncheng Hao, Baojuan Han, Guangchun Zeng, Lili Han, Cong Cao, Hui Liu, Zhenbin Zhong, Xue Zhao, Jingxuan Wang, Qingyuan Zhang
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 8331-8350 (2023)
Abstract Background RecQ‐mediated genome instability 2 (RMI2) maintains genome stability by promoting DNA damage repair. It has been reported to accelerate the progression of several tumors. However, the functional mechanism of RMI2 in breast cance
Externí odkaz:
https://doaj.org/article/3ed92e860c1546bfb75f719cff72d372
Autor:
Lihong Liu, Qingyuan Zhang, Hongtao Song, Yuwei Deng, Huilai Zhang, Xianhuo Wang, Jianli Ma, Xiaosan Zhang, Zirong Zhang, Caili Liu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/890e810e764c4848b080156055bbab9b
Publikováno v:
Translational Oncology, Vol 28, Iss , Pp 101614- (2023)
Objective: Follicular lymphoma (FL) occurring progression within 24 months (POD24) after initial immunochemotherapy has poor prognosis. GLUT1 affects glycolysis within tumor microenvironment (TME) and promotes tumor progression. However, its specific
Externí odkaz:
https://doaj.org/article/782defa1f4e249a4ae3bf1706aaf7acf
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Objective To investigate the prognostic value of derived neutrophil to lymphocyte ratio (dNLR) and lactate dehydrogenase (LDH) in patients with advanced HER2 positive breast cancer treated with trastuzumab emtansine. Methods Fifty one patien
Externí odkaz:
https://doaj.org/article/d8d02228af4443e5b80a3b2e92cf1eca